(Q46877809)

26 December 2017

title

Effects of portal free fatty acid elevation on insulin clearance and hepatic glucose flux (English)

1 reference

26 December 2017

0 references

13

Adria Giacca

1 reference

26 December 2017

author name string

Hidenori Yoshii

1

1 reference

26 December 2017

Tony K T Lam

2

1 reference

26 December 2017

Neehar Gupta

3

1 reference

26 December 2017

Tracy Goh

4

1 reference

26 December 2017

C Andrew Haber

5

1 reference

26 December 2017

Hiroshi Uchino

6

1 reference

26 December 2017

Tony T Y Kim

7

1 reference

26 December 2017

Victor Z Chong

8

1 reference

26 December 2017

Keyur Shah

9

1 reference

26 December 2017

I George Fantus

10

1 reference

26 December 2017

Andrea Mari

11

1 reference

26 December 2017

Ryuzo Kawamori

12

1 reference

26 December 2017

publication date

3 January 2006

1 reference

26 December 2017

American Journal of Physiology - Endocrinology and Metabolism

published in

1 reference

26 December 2017

volume

290

1 reference

26 December 2017

issue

6

1 reference

26 December 2017

page(s)

E1089-97

1 reference

26 December 2017

Peripheral effects of insulin dominate suppression of fasting hepatic glucose production

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00306.2005

Mechanisms linking diet and colorectal cancer: the possible role of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00306.2005

Prolonged elevation of plasma free fatty acids impairs pancreatic beta-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00306.2005

Insulin receptor internalization: molecular mechanisms and physiopathological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00306.2005

Hyperinsulinemia as an independent risk factor for ischemic heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00306.2005

Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00306.2005

Importance of peripheral insulin levels for insulin-induced suppression of glucose production in depancreatized dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00306.2005

Increased dependence of glucose production on peripheral insulin in diabetic depancreatized dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00306.2005

Pressor effects of portal venous oleate infusion. A proposed mechanism for obesity hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00306.2005

The dysmetabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00306.2005

In VitroInhibition of Insulin-Degrading Enzyme by Long-Chain Fatty Acids and Their Coenzyme A Thioesters

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00306.2005

Mechanism of free fatty acid effects on hepatocyte insulin receptor binding and processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00306.2005

Splanchnic free fatty acid kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00306.2005

Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00306.2005

The case of visceral fat: argument for the defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00306.2005

Differential effects of physiological versus pathophysiological plasma concentrations of epinephrine and norepinephrine on ketone body metabolism and hepatic portal blood flow in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00306.2005

Neural regulation of hepatic blood flow in rats: an in vivo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00306.2005

Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00306.2005

Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-delta

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00306.2005

The trafficking and processing of insulin and insulin receptors in cultured rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00306.2005

Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00306.2005

Effects of body fat distribution on regional lipolysis in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00306.2005

Prolonged elevation of plasma free fatty acids desensitizes the insulin secretory response to glucose in vivo in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00306.2005

Obesity and cardiovascular disease risk: research update

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00306.2005

Validation of a new method for determination of free fatty acid turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00306.2005

Extreme insulin resistance of the central adipose depot in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00306.2005

Measurement using tracers of steady-state turnover and metabolic clearance of insulin in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00306.2005

Splanchnic lipolysis in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00306.2005

Hypothalamic insulin signaling is required for inhibition of glucose production

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00306.2005

Splanchnic insulin metabolism in obesity. Influence of body fat distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00306.2005

Quantitative study of insulin secretion and clearance in normal and obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00306.2005

CEACAM1 regulates insulin clearance in liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00306.2005

Regional differences in triglyceride breakdown in human adipose tissue: effects of catecholamines, insulin, and prostaglandin E2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00306.2005

Effects of free fatty acids and glycerol on splanchnic glucose metabolism and insulin extraction in nondiabetic humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00306.2005

Basal hepatic glucose production is regulated by the portal vein insulin concentration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00306.2005

Free-fatty acid inhibition of insulin binding, degradation, and action in isolated rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00306.2005

Fatty acids in the portal vein of the rat regulate hepatic insulin clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00306.2005

10.1152/AJPENDO.00306.2005

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017